ATAdeba Tilahun

Adeba Tilahun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adeba Tilahun has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Isolation and Identification of Cyanobacteria and Its Plant Growth Promoting Efficacy using Maize (Zea mays) Seed Germination Experiment

    by Tefera Tadesse, Adeba Tilahun, Leta Tulu, Mulatu Workie

    Cyanobacteria are valuable biofertilizers due to their ability to improve nutrient availability and stimulate plant growth. This study investigated cyanobacterial isolates from maize rhizosphere soils collected from 16 maize-growing areas in Central, Oromia, and Southern Ethiopia. Cyanobacteria were isolated from maize rhizosphere soils using BG-11 culture medium and characterized through morphological and biochemical analyses. A total of 132 cyanobacterial isolates were obtained and screened for nitrogen-fixing ability on nitrogen-free BG-11 medium, phosphate-solubilizing activity on Pikovskaya’s agar, and siderophore production using the Chrome Azurol S (CAS) assay.A total Nine isolates showing both nitrogen fixation and phosphate solubilization were further characterized. All selected isolates were positive for catalase and oxidase activities, while eight produced siderophores. The germination promoting effects of cyanobacterial extracts were assessed using a Petri plate germination assay. Among them, isolate Tj~8~ recorded the highest phosphate-solubilization index (2.68). Seed germination experiments on maize varieties BH546 and BH547 revealed significantly higher germination rates in inoculated treatments than in the control. Tj~8~ produced the best individual performance, whereas the consortium Gt~12~ + Tj~8~ achieved the highest germination percentages. These findings suggest that selected cyanobacterial isolates have strong potential for development as eco-friendly biofertilizers for sustainable maize production.

  • Open Access

    Probiotics Application in the Treatment of Autoimmune Diseases and Enhancement of Efficacy Through Genetic Engineering

    by Betemariam Kebede, Adeba Tilahun

    The development of multidrug resistance in most pathogenic microorganisms and the rapidly increasing prevalence of non-communicable diseases are becoming major health concerns worldwide. Among non-communicable diseases, autoimmune diseases are caused mainly by imbalances in the gut microbiota (dysbiosis). Gut microbiota colonization and immune system establishment started in the early years of life. A defect in the gut microbiota predominantly affects the proper functioning of immune cells. Hence, restoring gut dysbiosis has received considerable attention for the last few decades as a potential therapeutic option. In this regard, probiotics have been the focus of research during recent decades because of their safe history of use along with fermented foods and beverages. Currently, advanced research is being conducted on the use of probiotics as immunomodulatory mediators and for the amelioration of gut dysbiosis as therapeutic adjuncts in the treatment of autoimmune diseases. In addition, probiotics are genetically engineered to enhance treatment efficacy and to develop live biotherapeutics (LBP). In this review, research articles summarizing findings in autoimmune disease treatment via probiotic strains, emphasizing type 1 diabetes, rheumatoid arthritis, Graves' disease, systemic lupus erythematosus and inflammatory bowel disease in both clinical trials and animal models, were reviewed. Finally, promising results of genetic engineering of probiotics for use as biosensors, delivery of therapeutic proteins, and diagnosis of infections were reported.